AKT1 and head and neck squamous cell carcinoma: Several genetic alterations causing PI3K/AKT/mTOR activation, such as activating mutations in the oncogene PI3KCA or inactivating mutations in the tumor suppressor protein PTEN, are driving CTX resistance in different HNSCC cell lines (125, 127).